John Lauerman

NORTH HALEDON, NJ – AUGUST 13: In this photo illustration, boxes of BinaxNow a COVID-19 at home test kit made by Abbott is seen on August 13, 2022 in North Haledon, New Jersey. The BinaxNOW COVID-19 Antigen Self-Test is an FDA-authorized at-home kit for detecting active infections using a shallow nasal swab to check for the presence of proteins from the virus that causes COVID-19. Maker of BinaxNow, Abbott reports a record-setting $3.3 billion in income in the opening three months of 2022. (Photo illustration by Michael Bocchieri/Getty Images)

Don’t toss those expired home COVID test kits. They may still be good after all

By Lindsey Rupp, John Lauerman, and others

Vegetables for sale at a wet market in Hong Kong, China, on Tuesday, Feb. 15, 2022. Hong Kongs leader said the city had no plans for a citywide lockdown to help bring cases back to zero, even as she acknowledged that a growing omicron outbreak has exceeded its capacity to respond. Photographer: Paul Yeung/Bloomberg via Getty Images

A new batch of COVID pills are in focus as daily life reopens. Here’s how the treatments work—and how well

By Jason Gale, John Lauerman, and others

MADRID, SPAIN – NOVEMBER 08: A woman receives the flu vaccine on the day the second phase of the vaccination campaign begins, at the Pozuelo de Alarcon Health Center, on November 8, 2021, in Pozuelo de Alarcon, Madrid, Spain. This November 8, the Community of Madrid begins the second phase of the vaccination campaign against seasonal influenza 2021/2022 for people over 60 years old, patients with chronic diseases, pregnant women, health and social health personnel, caregivers of vulnerable patients and staff of essential services. Coordinated by the General Directorate of Public Health, this second campaign will be carried out in 820 vaccination points distributed throughout the region. (Photo By Alberto Ortega/Europa Press via Getty Images)

Catching the common cold can help fend off COVID, study finds

By Tim Loh, John Lauerman, and others

Visitors at a Johnson & Johnson booth at the China International Import Expo (CIIE) in Shanghai, China, on Monday, Nov. 8, 2021. President Xi Jinping said at the opening of the CIIE on Thursday that China would continue to open up and seek cooperation in international organizations like the United Nations and World Trade Organization. Photographer: Qilai Shen/Bloomberg via Getty Images

Johnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart

By Riley Griffin, John Lauerman, and others

Merck COVID-19 pill

Merck says the U.S. will buy 1.4 million doses of its COVID-19 antiviral pill

By John Lauerman and Bloomberg

31 July 2021, Bavaria, Nuremberg: Illustration – Ampoules with the Corona vaccine from Johnson & Johnson stand on a table in the temporary vaccination center at the amusement park “Nürnbärland”. On Saturday, visitors, showmen or staff of the park can be immunized against the Corona virus without an appointment. Photo: Daniel Karmann/dpa (Photo by Daniel Karmann/picture alliance via Getty Images)

FDA advisors unanimously back Johnson & Johnson COVID boosters for people 18 and older

By John Lauerman and Bloomberg

LOUISVILLE, KY – FEBRUARY 12: A woman is administered her Moderna COVID-19 vaccine by a medical technician in Bates Memorial Baptist Church February 12, 2021 in Louisville, Kentucky. Friday marked the first day that Norton Healthcare offered the vaccination in predominantly black areas of the city, with black churches being the operation centers for the pop-up clinics. (Photo by Jon Cherry/Getty Images)

What you need to know about severe reactions to COVID vaccines

By John Lauerman, Jason Gale, and others

COVID vaccine second shot, dose

What to know about delaying second COVID vaccine shots as countries grapple with limited supplies

By John Lauerman, Jason Gale, and others

Health Workers Administer Covid-19 Vaccines At Bronx Nursing Home

Everything to know about allergic reactions to COVID vaccines

By John Lauerman and Bloomberg

Syringes wand vials of the Pfizer-BioNTech COVID-19 vaccine are prepared to be administered to front-line health care workers under an emergency use authorization at a drive up vaccination site from Renown Health in Reno, Nev. on December 17, 2020.

Pfizer to supply U.S. with 100 million more vaccine doses

By John Lauerman, Riley Griffin, and others

Shares in AstraZeneca were down 1% after the drugmaker disclosed it was pausing its COVID-19 vaccine trial. Initially, that sent markets lower, before recovering.

AstraZeneca acquires rare-disease specialist Alexion in $39 billion deal

By John Lauerman, James Paton, and others

Dr. Anthony Fauci Testifies Before Senate On Federal Response To Pandemic

Anthony Fauci tones down earlier criticism of U.K.’s Pfizer vaccine approval

By John Lauerman, Mike Dorning, and others

Researchers continue to puzzle over why the COVID vaccine developed by AstraZeneca and Oxford University appears to be more effective on a half dose. Wire photography: Lisa Maree Williams—Getty Images

For AstraZeneca’s COVID vaccine, less may be more—and that’s puzzling researchers

By Angelica LaVito, John Lauerman, and others

People are reflected in a bus stop window as they walk past the Pfizer world headquarters in Midtown Manhattan on July 29, 2019 in New York City. On Wednesday, the U.S. government announced it would buy up to 600 million doses of a vaccine in development with BioNTech

U.S. government secures 100 million doses of Pfizer, BioNTech vaccine for $2 billion

By John Lauerman and Bloomberg

CHINA-HEALTH-VIRUS

The earliest coronavirus vaccines may not protect you from getting infected

By John Lauerman, James Paton, and others